Royal Bank Of Canada Axsome Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 15,648 shares of AXSM stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,648

Previous 16,144 3.07%

Holding current value

$1.42 Million

Previous $1.3 Million 8.16%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $39,149 - $47,536	-496 Reduced 3.07%	15,648 $1.41 Million
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $8,609 - $10,545	131 Added 0.82%	16,144 $1.3 Million
Q1 2024 Nov 05, 2024	SELL	$69.39 - $97.64 $9,090 - $12,790	-131 Reduced 0.81%	16,013 $1.28 Million
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $709,443 - $998,271	-10,224 Reduced 38.97%	16,013 $1.28 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $366,569 - $533,766	6,384 Added 32.16%	26,237 $2.09 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $867,010 - $1.03 Million	12,520 Added 170.74%	19,853 $1.39 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $111,504 - $172,478	1,909 Added 35.2%	7,333 $526,000
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $172,192 - $221,175	-2,949 Reduced 35.22%	5,424 $334,000
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $154,847 - $309,074	3,877 Added 86.23%	8,373 $645,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $25,674 - $49,733	712 Added 18.82%	4,496 $201,000
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $45,175 - $97,146	-2,078 Reduced 35.45%	3,784 $144,000
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $90,154 - $157,447	-3,804 Reduced 39.35%	5,862 $242,000
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $89,644 - $126,611	2,920 Added 43.28%	9,666 $365,000
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $63,871 - $218,978	3,208 Added 90.67%	6,746 $223,000
Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $179,128 - $260,043	3,538 New	3,538 $238,000

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Axsome Therapeutics, Inc. Transaction History